Australia
December 21, 2021
The Office of the Gene Technology Regulator (OGTR) has received a licence application (DIR 188) from Nuseed Pty Ltd to conduct a field trial of genetically modified (GM) canola and Indian mustard with altered oil content and herbicide tolerance. A summary of the application is posted on our website.
The trial is proposed to take place between November 2022 and December 2027, at up to 20 trial sites per year with a maximum area of 150 hectares per year. The trial sites are located in New South Wales, Victoria and Queensland. The trial would be subject to control measures that restrict the spread and persistence of the GM plants and their introduced genetic material. The GM canola and Indian mustard would not be used for commercial human food or animal feed.
The OGTR is preparing a Risk Assessment and Risk Management Plan for the application. This is expected to be released for public comment and advice from experts, agencies and authorities in March 2022. There will be at least 30 days for submission of comments.
If you have any questions or would like to receive a copy of the full application or the summary, please contact the OGTR and quote the reference number DIR 188.
Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601
Telephone: 1800 181 030 E-mail: ogtr@health.gov.au
OGTR website
DIR 188
Limited and controlled release of canola and Indian mustard genetically modified for altered oil content and herbicide tolerance
Licence details
Licence number: DIR 188
Licence status: Application under evaluation
Category: Agricultural
Release: Limited and controlled
Organisation: Nuseed Pty Ltd
Date application received: 12 November 2021
Documents
Licence application - notification
Information for the public and stakeholders that the Regulator has received an application for a licence. It provides early information about the application and the assessment process including a future opportunity for public submissions.
Licence application - summary
A summary of the application including brief description of the GMO(s) and proposed work with GMO(s). Also explains the assessment and public consultation process.
Topics
Species
